Hybel, T. E., Vase, M. Ø., Maksten, E. F.
, Enemark, M. B., Lauridsen, K. L., Hamilton-Dutoit, S., Andersen, C., Møller, M. B., Sørensen, S. S.
, Jespersen, B., Kampmann, J.
, d'Amore, F. & Ludvigsen, M. (2021).
Intratumoral expression of CD38 in patients with post-transplant lymphoproliferative disorder.
Acta Oncologica,
60(12), 1637-1642.
https://doi.org/10.1080/0284186X.2021.1973093
Beck Enemark, M., Monrad, I., Madsen, C., Lystlund Lauridsen, K., Honoré, B., Plesner, T. L.
, Hamilton-Dutoit, S. J., d'Amore, F. & Ludvigsen, M. (2021).
PD-1 Expression in Pre-Treatment Follicular Lymphoma Predicts the Risk of Subsequent High-Grade Transformation.
OncoTargets and Therapy,
14, 481-489.
https://doi.org/10.2147/OTT.S289337
Vajavaara, H., Ekeblad, F., Holte, H.
, Jorgensen, J., Leivonen, S.-K., Berglund, M.
, Kamper, P., Moller, H. J., D'Amore, F., Molin, D., Enblad, G.
, Ludvigsen, M., Glimelius, I. & Leppa, S. (2021).
Prognostic impact of soluble CD163 in patients with diffuse large Bcell lymphoma.
Haematologica,
106(9), 2502-2506.
https://doi.org/10.3324/haematol.2020.278182Ludvigsen, M., Thorlacius-Ussing, L., Vorum, H.
, Stender, M. T., Thorlacius-Ussing, O.
& Honoré, B. (2021).
Proteomic Characterization of Colorectal Cancer Tissue from Patients Identifies Novel Putative Protein Biomarkers.
Current issues in molecular biology,
43(2), 1043-1056.
https://doi.org/10.3390/cimb43020074
Holst, J. M., Enemark, M. B., Pedersen, M. B., Lauridsen, K. L., Hybel, T. E., Clausen, M. R., Frederiksen, H., Møller, M. B., Nørgaard, P., Plesner, T. L.
, Hamilton-Dutoit, S. J., D’amore, F., Honoré, B. & Ludvigsen, M. (2021).
Proteomic profiling differentiates lymphoma patients with and without concurrent myeloproliferative neoplasia.
Cancers,
13(21), Article 5526.
https://doi.org/10.3390/cancers13215526
Vajavaara, H.
, Mortensen, J. B., Leivonen, S.-K.
, Hansen, I. M., Ludvigsen, M., Holte, H.
, Jørgensen, J., Bjerre, M., d'Amore, F. & Leppä, S. (2021).
Soluble PD-1 but Not PD-L1 Levels Predict Poor Outcome in Patients with High-Risk Diffuse Large B-Cell Lymphoma.
Cancers,
13(3), Article 398.
https://doi.org/10.3390/cancers13030398Mortensen, J. B., Monrad, I., Enemark, M. B., Ludvigsen, M., Kamper, P., Bjerre, M. & d'Amore, F. (2021).
Soluble programmed cell death protein 1 (sPD-1) and the soluble programmed cell death ligands 1 and 2 (sPD-L1 and sPD-L2) in lymphoid malignancies.
European Journal of Haematology,
107(1), 81-91.
https://doi.org/10.1111/ejh.13621
Kim, S. J., Lim, J. Q., Laurensia, Y., Cho, J., Yoon, S. E., Lee, J. Y., Ryu, K. J., Ko, Y. H., Koh, Y., Cho, D., Lim, S. T.
, Beck Enemark, M., D'amore, F., Bjerre, M., Ong, C. K. & Kim, W. S. (2020).
Avelumab for the treatment of relapsed or refractory extranodal NK/T-cell lymphoma: an open-label phase 2 study.
Blood,
136(24), 2754-2763.
https://doi.org/10.1182/blood.2020007247Soerensen, J. F., Aggerholm, A., Kerndrup, G. B.
, Hansen, M. C., Ewald, I. K. L., Bill, M., Ebbesen, L. H., Rosenberg, C. A., Hokland, P., Ludvigsen, M. & Stidsholt Roug, A. (2020).
Clonal hematopoiesis predicts development of therapy-related myeloid neoplasms post-autologous stem cell transplantation.
Blood Advances,
4(5), 885-892.
https://doi.org/10.1182/bloodadvances.2019001157
Monrad, I., Madsen, C., Lauridsen, K. L., Honoré, B., Plesner, T. L.
, Hamilton-Dutoit, S., D’Amore, F. & Ludvigsen, M. (2020).
Glycolytic biomarkers predict transformation in patients with follicular lymphoma.
PLoS One,
15(5), Article e0233449.
https://doi.org/10.1371/journal.pone.0233449
Holst, J. M., Ludvigsen, M., Hamilton-Dutoit, S. J., Bendix, K., Plesner, T. L., Nørgaard, P., Møller, M. B.
, Steiniche, T., Rabinovich, G. A.
, d'Amore, F. & Pedersen, M. B. (2020).
High intratumoural galectin-1 expression predicts adverse outcome in ALK- ALCL and CD30+ PTCL-NOS.
Hematological Oncology,
38(1), 59-66.
https://doi.org/10.1002/hon.2702
Holst, J. M., Plesner, T. L.
, Pedersen, M. B., Frederiksen, H., Møller, M. B.
, Clausen, M. R., Hansen, M. C., Hamilton-Dutoit, S. J., Nørgaard, P., Johansen, P.
, Eberlein, T. R., Mortensen, B. K., Mathiasen, G., Øvlisen, A., Wang, R., Wang, C., Zhang, W.
, Ommen, H. B., Stentoft, J. ... d'Amore, F. (2020).
Myeloproliferative and lymphoproliferative malignancies occurring in the same patient: a nationwide discovery cohort.
Haematologica,
105(10), 2432-2439.
https://doi.org/10.3324/haematol.2019.225839
Ludvigsen, M., Thorlacius-Ussing, L., Vorum, H., Moyer, M. P.
, Stender, M. T., Thorlacius-Ussing, O.
& Honoré, B. (2020).
Proteomic Characterization of Colorectal Cancer Cells versus Normal-Derived Colon Mucosa Cells: Approaching Identification of Novel Diagnostic Protein Biomarkers in Colorectal Cancer.
International Journal of Molecular Sciences ,
21(10), Article 3466.
https://doi.org/10.3390/ijms21103466
Madsen, C., Plesner, T. L.
, Bentzen, H. H. N., Jørgensen, J. M., Sillesen, I. B., Himmelstrup, B. M., Josefsson, P., Plesner, T., Bennedsen, T. L.
, Ludvigsen, M. & d'Amore, F. A. (2020).
Real world data on histological transformation in patients with follicular lymphoma: incidence, clinico-pathological risk factors and outcome in a nationwide Danish cohort.
Leukemia & Lymphoma,
61(11), 2584-2594 .
https://doi.org/10.1080/10428194.2020.1779254
Hybel, T. E., Dietrichs, D.
, Sahana, J., Corydon, T. J., Nassef, M. Z.
, Wehland, M., Krüger, M.
, Magnusson, N. E., Bauer, J., Utpatel, K., Infanger, M.
, Grimm, D. & Kopp, S. (2020).
Simulated Microgravity Influences VEGF, MAPK, and PAM Signaling in Prostate Cancer Cells.
International Journal of Molecular Sciences ,
21(4), Article E1263.
https://doi.org/10.3390/ijms21041263
Snipsøyr, M. G., Wiggers, H., Ludvigsen, M., Stensballe, A., Vorum, H., Poulsen, S. H., Rasmussen, L. M.
, Petersen, E. & Honoré, B. (2020).
Towards identification of novel putative biomarkers for infective endocarditis by serum proteomic analysis.
International Journal of Infectious Diseases,
96, 73-81.
https://doi.org/10.1016/j.ijid.2020.02.026
Simonsen, A. T., Bill, M., Rosenberg, C. A., Hansen, M. H., Møller, P. L., Kjeldsen, E., Johansen, K. D., Ommen, H. B., Nederby, L.
, Aggerholm, A., Hokland, P. & Ludvigsen, M. (2020).
Unraveling clonal heterogeneity at the stem cell level in myelodysplastic syndrome: In pursuit of cell subsets driving disease progression.
Leukemia Research,
92, Article 106350.
https://doi.org/10.1016/j.leukres.2020.106350
Madsen, C., Lauridsen, K. L., Plesner, T. L., Monrad, I.
, Honoré, B., Hamilton-Dutoit, S., d’Amore, F. & Ludvigsen, M. (2019).
High intratumoral expression of vimentin predicts histological transformation in patients with follicular lymphoma.
Blood Cancer Journal,
9(4), Article 35.
https://doi.org/10.1038/s41408-019-0197-5
Hansen, M. C., Cedile, O.
, Ludvigsen, M., Kjeldsen, E., Moeller, P. L., Abildgaard, N.
, Hokland, P. & Nyvold, C. G. (2019).
Integrating detection of copy neutral chromosomal losses in a clinical setting in leukemia and lymphoma by means of allelic imbalance and read depth ratio comparison.
https://doi.org/10.1101/590752